Clinical Trials Logo

Clinical Trial Summary

Cerebellocerebral connection plays an important function in motor control. Nowadays it can be investigated with neuroimaging and physiological methods in humans. Cerebellar inhibition (CBI) is a phenomenon showing a physiological suppression of the motor evoked potential (MEP) evoked from the motor cortex (M1) by delivering a preceding transcranial magnetic stimulation (TMS) on the contralateral cerebellum. Despite the mediated pathway is supposed to be the cerebello-dentato-thalamo-cortical (CDTC) circuit, there is no conclusive evidence. In addition, the clinical significant of CBI remains unclear. Based on our previous studies, we found that the patients with advanced tremor show an impaired Bereitschaftspotential. The findings support a notion that the patients with tremor bear dysfunction of the CDTC circuit. Intriguingly, the pathogenesis of the parkinsonian tremor is highly associated with the CDTC circuit. The "dimmer-switch" model suggests that the basal ganglia-thalamo-cortical circuit dysfunction may initiate the resting tremor, and the following CDTC circuit dysfunction will lead to the large-amplitude resting and postural tremor in Parkinson's disease (PD). The intention tremor is usually found in the patients with cerebellar degeneration, which is also relevant to the CDTC circuit dysfunction. We expect that the clinical significance of CBI and the mediated pathway of CBI will be clarified by this study.


Clinical Trial Description

The patients with hereditary cerebellar degeneration usually present intention tremor. Whether the intention tremor and the other cerebellar signs are correlated with their CBI finding remains unclear. By measuring the excitability curve (or input-output curve) of the CBI, we will be able to clarify this issue. We will first examine the relationship between CBI and clinical manifestations, particularly the different tremor types. Any CBI change following the PTT intervention in the PD patients will provide an excellent opportunity to investigate the relevance of the basal ganglia-thalamo-cortical circuit with CBI. The DTI findings will provide additional support to our hypothesis. In the first part of the study, we will recruit twenty age-matched patients into the three groups: PD with pure resting tremor, PD with postural tremor and cerebellar degeneration with intention tremor. They will receive clinical assessments, deep phenotyping with eye tracking, tremor recording and gait analysis. Diffusion tensor imaging focusing on pallidothalamic and dentatothalamic tractography will be done. The excitability curve of CBI will be examined with five TMS intensity steps. We suppose that there will be a gradient correlation of the CBI with the three tremor groups and the two diffusion tensor imaging tracts. In the second part of the study, we will follow up the PD patients who receive the pallidothalamic tractotomy via magnetic resonance imaging-guided focus ultrasound (MRg-FUS). Twelve PD patients with pure resting tremor and twelve PD patients with postural tremor will be monitored for one year. The pallidothalamic tractotomy provides an excellent opportunity to verify our findings in the first part. We suppose that the CBI change will occur in the patients with postural tremor instead of those with pure resting tremor. In summary, we expect that the clinical significance of CBI and the mediated pathway of CBI will be clarified by this study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05512299
Study type Observational
Source China Medical University Hospital
Contact Ming-Kuei Lu, MD, PhD
Phone 8864-22052121
Email d4297@mail.cmuh.org.tw
Status Recruiting
Phase
Start date August 1, 2022
Completion date July 31, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02427646 - Kinematic-guided BoNT-A Treatment for ET and PD Tremor Phase 2
Completed NCT01018485 - The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor Phase 3
Completed NCT02087046 - Deep Brain Stimulation (DBS) for the Suppression of Tremor N/A
Recruiting NCT05413291 - Natural History Protocol for Movement Disorders
Recruiting NCT04654429 - Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients? Phase 4
Recruiting NCT04825119 - Hyperkinetic Movements in Patients With Disease of Motor Neurons and Their Response to Treatment With Nusinersen
Recruiting NCT05150106 - Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
Completed NCT05152836 - The Effect of Vibrotactile Stimulation on Parkinson's Tremor N/A
Recruiting NCT04071847 - Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Completed NCT02046863 - Pilot Study for Automated Deep Brain Stimulation Programming N/A
Not yet recruiting NCT06378619 - Tapping Test and the Archimedean Spiral for the Differential Diagnosis of Tremor. Machine Learning Approach
Completed NCT03300193 - The Effect of Lesion Characteristics in MRgFUS on Tremor in Essential Tremor and Parkinson's Disease N/A
Completed NCT01932463 - ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) for Treatment of Tremor N/A
Recruiting NCT05216770 - Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor Early Phase 1
Not yet recruiting NCT06174948 - The Use of the CUE1 in People With Parkinson's Disease and Related Disorders N/A
Completed NCT01093027 - Electrophysiological Study of the Effects of Limb Cooling on Essential Tremor N/A
Completed NCT00001667 - Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases N/A
Completed NCT00001324 - PET Scan to Study Brain Control of Human Movement
Completed NCT04299087 - Repetitive Transcranial Magnetic Stimulation (rTMS) for Dystonia and Tremor N/A
Recruiting NCT05150093 - Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor N/A